EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A double-blind, randomized, placebo-controlled study to evaluate the efficacy of Oxybutynin Chloride Extended-Release tablets on the double-J stent related symptoms following uncomplicated ureteroscopic lithotripsy

Kuo-How Huang, Tsung-Yi Hsieh, Po-Ming Chow, Yuan-Ju Lee, Hsu-Che Huang, I-Ni Chiang, Teng-Kai Yang

Urolithiasis · 2025

DOI: 10.1007/s00240-025-01725-0 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Urolithiasis, 2025. Verfasst von Kuo-How Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Taiwan, National Taiwan University Hospital, University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Mandelic Acids, Stents, Ureteroscopy, Lithotripsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the effects of Oxybutynin Chloride Extended-Release Tablets (Oxbu) on double-J stent-related symptoms following uncomplicated ureterosocpic lithotripsy (URSL). This is a double-blind, randomized, placebo-controlled study with a total of 120 subjects with ureteral calculi receiving double-J stent insertion following URSL. Subjects who meet the inclusion and exclusion criteria will be randomly assigned to Oxbu or placebo group. All patients completed a structured questionnaire assessing the stent-related symptoms one week after operation. The clinical data and stent characteristics were recorded as well. The severity of stent-related symptoms was compared between two groups. The mean age were 58.2 years both in Oxbu group and control group, and the demographic data were all comparable between the two groups. Oxbu group had significant improvement for stent related pain score (-0.47 points, P < 0.01) and quality of life score (-0.17 points, P < 0.01) compared to the control group. The male subgroup showed that Oxbu had less urgency item score (-0.59 points, P < 0.05). The subgroup analysis for female showed that Oxbu had more decrease in the intermittency item score (-0.89 points, P = 0.043) and aged < 50 showed Oxbu had more decrease in Overactive Bladder Symptoms Score total score and urgency item score (-0.8 and - 0.6 points, all P < 0.05). This study showed that Oxbu decreases the severity of double-J stent related pain and the quality of life score for patients received URSL. In the IPSS and OABSS item, the intermittency and urgency are improved in the Oxbu group. In conclusion, Oxbu treatment had beneficial effects to improve the severity of stent related symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mandelic AcidsStentsUreteroscopyLithotripsyUreteral CalculiMuscarinic AntagonistsPostoperative PainHumansMaleFemaleMiddle AgedDouble-Blind MethodDelayed-Action PreparationsQuality of LifeAgedAdultTabletsTreatment Outcome

Stichwörter der Autor:innen

Lower urinary tract symptomsOxybutynin chlorideUreteral stent

Substanzen

Mandelic AcidsoxybutyninDelayed-Action PreparationsTabletsMuscarinic Antagonists

Autor:innen und Institutionen

  • Department of Urology, National Taiwan, National Taiwan University Hospital, University College of Medicine, Taipei, Taiwan.
  • Division of Urology, Department of Surgery, Yonghe Cardinal Tien Hospital, New Taipei City, Taiwan.
  • Department of Life Science, College of Science, National Taiwan Normal University, Taipei, Taiwan.
  • Division of Urology, Department of Surgery, Yonghe Cardinal Tien Hospital, New Taipei City, Taiwan. circulas1@gmail.com.
  • School of Medicine, College of Medicine, Fu-Jen Catholic University, No.80, Zhongxing St., Yonghe Dist, New Taipei City, 234403, Taiwan. circulas1@gmail.com.

Zitieren

APA

Huang, K. H., Hsieh, T. Y., Chow, P. M., Lee, Y. J., Huang, H. C., Chiang, I. N., & Yang, T. K. (2025). A double-blind, randomized, placebo-controlled study to evaluate the efficacy of Oxybutynin Chloride Extended-Release tablets on the double-J stent related symptoms following uncomplicated ureteroscopic lithotripsy. Urolithiasis. https://doi.org/10.1007/s00240-025-01725-0

Vancouver

Huang KH, Hsieh TY, Chow PM, Lee YJ, Huang HC, Chiang IN, et al. A double-blind, randomized, placebo-controlled study to evaluate the efficacy of Oxybutynin Chloride Extended-Release tablets on the double-J stent related symptoms following uncomplicated ureteroscopic lithotripsy. Urolithiasis. 2025. doi:10.1007/s00240-025-01725-0

BibTeX
@article{Huang2025,
  author = {Huang, Kuo-How and Hsieh, Tsung-Yi and Chow, Po-Ming and Lee, Yuan-Ju and Huang, Hsu-Che and Chiang, I-Ni and Yang, Teng-Kai},
  title = {A double-blind, randomized, placebo-controlled study to evaluate the efficacy of Oxybutynin Chloride Extended-Release tablets on the double-J stent related symptoms following uncomplicated ureteroscopic lithotripsy},
  journal = {Urolithiasis},
  year = {2025},
  doi = {10.1007/s00240-025-01725-0}
}
Kostenlos starten →